Sign in
4

Changes in Ownership

Spyre Therapeutics, Inc. Filed Acc 0001209191-20-026662

President & CEO bought 165,000 shares at $4.75 ($783,750)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Quinn Anthony G. President & CEO 2020-04-30 Purchase +165,000 $4.75 $783,750 538,469 D: show line 1 in the form
Open-market purchases · 165,000 sh · avg $4.75 · $783,750
Loading xslF345X03/doc4.xml…